A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
Clinical trial NCT01285323 · COMPLETED
Trial details
- NCT number
- NCT01285323
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2014-04-01
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.